🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will look at how a known study medicine N8-GP works in previousl...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2018-04-30
Trial ID
NCT03528551
Treatments Being Tested
The purpose of this study is to assess the safety and effectiveness of Espe...
Status
Completed
Location
Kurume University Hospital, Pediatrics
Start Date
2021-03-31
Trial ID
NCT04334057
Treatments Being Tested
Investigating single dose pharmacokinetics and safety of turoctocog alfa pe...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2016-10-04
Trial ID
NCT02920398
Treatments Being Tested
The trial is conducted in Asia, Europe and North America. The aim of the st...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2017-01-30
Trial ID
NCT02994407
Treatments Being Tested
This trial is conducted globally. The aim of the trial is to investigate sa...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2013-02-20
Trial ID
NCT01731600
Treatments Being Tested
This study will collect information on the long term health of joints in pe...
Status
Recruiting
Location
Novo Nordisk Investigational Site
Start Date
2022-11-23
Trial ID
NCT05621746
Treatments Being Tested
This study will collect information on side effects and how well Esperoct® ...
Status
Enrolling By Invitation
Location
AKH - Klin. Abt. f. Haematologie u. Haemostaseologie
Start Date
2020-10-23
Trial ID
NCT04574076
Treatments Being Tested
This trial is conducted globally. The aim of the trial is to investigate th...
Status
Completed
Location
Arizona H&T Phoenix Child Hosp
Start Date
2014-06-26
Trial ID
NCT02137850
Treatments Being Tested
The study investigates how well the medicine called turoctocog alfa pegol (...
Status
Completed
Location
Beijing Children's Hospital, Capital Medical University
Start Date
2021-09-27
Trial ID
NCT05082116
Treatments Being Tested